NEOG

Business Context and Reporting Period

Company: Neogen Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended February 29, 2004
Business Overview: Neogen operates two reportable segments: Food Safety (diagnostic test kits for toxins, bacteria, and allergens) and Animal Safety (veterinary instruments, rodenticides, and disinfectants). The company is incorporated in Michigan.

Key Financial Metrics

Note: All financial figures are in thousands unless otherwise noted. Cash flow from operating activities for the nine months ended Feb 29, 2004, was $925,000.

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 29.1% ($3.3M) for the quarter and 14.3% ($5.0M) for the nine-month period compared to the prior year.
  • Animal Safety Segment: Drove the majority of growth with a 60.9% quarterly increase, largely due to the November 2003 acquisitions of Hacco, Inc. and Hess & Clark, Inc. Organic growth in veterinary instruments also contributed (26.5% increase).
  • Food Safety Segment: Increased 4.6% for the quarter. Growth was offset by a decline in natural toxin test kits due to a lack of aflatoxin contamination in the 2003 crop compared to the prior year. Sales of GMO test kits to Brazil provided a significant boost.
• Profitability: Net income rose 15% for the quarter ($1.18M vs $1.03M) and 15% for the nine months ($4.03M vs $3.51M).
  • Margins: Gross margins declined from 53.0% to 47.1% (quarter) and 54.5% to 50.2% (nine months) due to the lower-margin product mix from the new acquisitions.
• Balance Sheet: Long-term debt increased from $0 to $4.6M due to a new $15M revolving credit facility utilized for acquisitions and facility purchases. Cash and marketable securities decreased by $7.3M from the prior fiscal year-end, primarily due to acquisition costs.

Guidance, Outlook, and Risks

• Guidance: Management explicitly states it does not provide forecasts of future performance. Historical results are not necessarily indicative of future performance.
• Acquisition Integration: Integration costs for Hacco and Hess & Clark are expected to continue into early fiscal 2005, though they may begin to abate in the fourth quarter. Contingent consideration of up to $450,000 remains possible for the Adgen Ltd. acquisition if revenue targets are met.
• Liquidity: The company has $1.6M in cash and $10.4M available on its bank line. Management believes this is sufficient for foreseeable needs but may require equity issuance or additional financing for future product commercialization or acquisitions.
• Risks:
  • Weather Dependence: Agricultural and food production markets are sensitive to weather conditions (e.g., aflatoxin levels).
  • Competition: Increased competition in E. coli testing markets.
  • Foreign Exchange: Minimal hedging is performed; operations in Scotland expose the company to currency fluctuations, though balances are currently considered insignificant.

Investor Verification Checklist

• Acquisition Impact: Verify the long-term margin contribution of the Hacco and Hess & Clark acquisitions versus the current drag on gross margins.
• Seasonality and Weather: Assess the volatility of the Food Safety segment's revenue, specifically regarding natural toxin testing which is highly dependent on crop contamination levels.
• Debt Covenants: Review the terms of the new $15M revolving credit facility (maturing Sept 2005) and ensure compliance with current ratio and debt-to-earnings covenants.
• Contingent Liabilities: Monitor the Adgen Ltd. acquisition for potential future cash outflows if revenue targets are achieved.
• Stock Split: Confirm that all per-share data has been adjusted for the 5-for-4 stock split effective January 2, 2004.